Immunoclin (Immunoclin) ROE % Adjusted to Book Value : -20.93% (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin ROE % Adjusted to Book Value?

Immunoclin's ROE % for the quarter that ended in Oct. 2014 was -137.48%. Immunoclin's PB Ratio for the quarter that ended in Oct. 2014 was 6.57. Immunoclin's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2014 was -20.93%.

Immunoclin ROE % Adjusted to Book Value Historical Data

The historical data trend for Immunoclin's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin ROE % Adjusted to Book Value Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

ROE % Adjusted to Book Value

-49.72

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
ROE % Adjusted to Book Value	Get a 7-Day Free Trial									-1.28	-1.24	-3.21	-7.31	-20.93

Competitive Comparison of Immunoclin's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Immunoclin's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunoclin's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Immunoclin's ROE % Adjusted to Book Value falls into.

Immunoclin ROE % Adjusted to Book Value Calculation

Immunoclin's ROE % Adjusted to Book Value for the fiscal year that ended in Jan. 2014 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-129.77%	/	2.61
	=	-49.72%

Immunoclin's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2014 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-137.48%	/	6.57
	=	-20.93%

Immunoclin ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Immunoclin's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines